P

Inventor

MCKITTRICK BRIAN A

US35 patents
⚠️ This page may combine multiple inventors who share the name “MCKITTRICK BRIAN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

22 patents
USRE37721EMay 28, 2002

Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents

SCHERING CORP99 citations99
US5846966ADec 8, 1998

Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors

SCHERING CORP171 citations99
US6689765B2Feb 10, 2004

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP71 citations97
US6391865B1May 21, 2002

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP94 citations97
US6387930B1May 14, 2002

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP76 citations96
US5824683AOct 20, 1998

2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones

SCHERING CORP70 citations96
US5744467AApr 28, 1998

Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents

SCHERING CORP77 citations96
US5633246AMay 27, 1997

Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents

SCHERING CORP91 citations96
US5624920AApr 29, 1997

Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents

SCHERING CORP88 citations96
US6602885B2Aug 5, 2003

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP21 citations92
US5476847ADec 19, 1995

Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors

SCHERING CORP25 citations92
US6458812B1Oct 1, 2002

Muscarinic antagonists

SCHERING CORP56 citations91
US7700601B2Apr 20, 2010

Substituted indazoles of formula 1.0 that are kinase inhibitors

SCHERING CORP38 citations90
US6472394B1Oct 29, 2002

MCH antagonists and their use in the treatment of obesity

SCHERING CORP24 citations89
USRE42461EJun 14, 2011

Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents

SCHERING CORP7 citations84
US7700603B2Apr 20, 2010

Heterocyclic aspartyl protease inhibitors

SCHERING CORP9 citations84
US7528132B2May 5, 2009

Kinase inhibitors

SCHERING CORP14 citations83
US7638526B2Dec 29, 2009

Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism

SCHERING CORP8 citations82
US7384944B2Jun 10, 2008

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP6 citations73
US7723342B2May 25, 2010

Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia

SCHERING CORP4 citations63
US7902157B2Mar 8, 2011

Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism

SCHERING CORP1 citations52
US7361769B2Apr 22, 2008

Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders

SCHERING CORP0 citations41

SCHERING PLOUGH CORP

3 patents

AMERICAN HOME PROD

3 patents

ZHU ZHAONING

2 patents

ASLANIAN ROBERT G

1 patent

CHAN TIN-YAU

1 patent

BAROUDY BAHIGE M

1 patent

CLASBY MARTIN C

1 patent

TSUI HON-CHUNG

1 patent